CluenexAmdocs DOX
Amdocs scores average on business quality (4.6 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Amdocs does
Amdocs provides billing, customer management, and digital software products to major telecommunications service providers worldwide, handling core operational workloads for telecom giants.
- What it does best
Amdocs dominates mission-critical billing systems for global telecom operators, locking in enterprise clients through deeply embedded software integrations that are notoriously difficult to rip out. This scale supports a steady free cash flow of $639 million.
- The main risk
Top-line shrinkage threatens its core operating model, with revenue contracting 9.4% to $4.7 billion as major telecom clients pare back IT spending and modernization budgets.
Quality, check by check
Scored against its own industry, from company filings.
Operating margins stand at 17.8% while free cash flow conversion remains robust, producing $639 million in cash. However, compressed margins from declining revenue suggest the business loses some efficiency as scale contracts.
Switching costs form its primary moat, locking in large telecom operators who rely on its billing software for daily operations. Its operating margin sits in the top quartile of its sector at the 57th percentile, reflecting durable pricing power.
Revenue is shrinking at 9.4%, a sharp deterioration compared to prior annual periods where top-line figures hovered near $5.0 billion, indicating that growth has stalled across its primary markets.
With a debt-to-equity ratio of 0.2 and cash holdings of $325 million against $647 million of total debt, the balance sheet remains sound while generating $639 million in free cash flow, pointing to steady financial footing.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on DOX
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Amdocs scores average on the Cluenex quality check (4.6 of 10), measured against its own industry. Profitability is fair, moat fair, growth slow and financial health fair.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Nov 9, 2026, after the close.
See DOX today
- Today's verdict on DOX, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Amdocs (DOX)”, https://cluenex.com/stocks/dox/, data as of Oct 10, 2026.